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Protein quality control is an essential function of the endoplasmic reticulum. Misfolded proteins
unable to acquire their native conformation are retained in the endoplasmic reticulum, retro-
translocated back into the cytosol, and degraded via the ubiquitin-proteasome system. We show
that efficient degradation of soluble malfolded proteins in yeast requires a fully competent early
secretory pathway. Mutations in proteins essential for ER-Golgi protein traffic severely inhibit ER
degradation of the model substrate CPY*. We found ER localization of CPY* in WT cells, but no
other specific organelle for ER degradation could be identified by electron microscopy studies.
Because CPY* is degraded in COPI coat mutants, only a minor fraction of CPY* or of a protein-
aceous factor required for degradation seems to enter the recycling pathway between ER and
Golgi. Therefore, we propose that the disorganized structure of the ER and/or the mislocalization
of Kar2p, observed in early secretory mutants, is responsible for the reduction in CPY* degrada-
tion. Further, we observed that mutations in proteins directly involved in degradation of mal-
folded proteins (Der1p, Der3/Hrd1p, and Hrd3p) lead to morphological changes of the endo-
plasmic reticulum and the Golgi, escape of CPY* into the secretory pathway and a slower
maturation rate of wild-type CPY.
INTRODUCTION
Protein quality control with subsequent elimination of mal-
folded proteins or unassembled subunits is essential for
cellular function. Disturbed quality control leads to disease
and eventually to cell death (Plemper and Wolf, 1999; Ko-
pito and Sitia, 2000). The endoplasmic reticulum (ER) is the
folding compartment for proteins destined to function
within the ER itself and for secretory proteins of the Golgi,
endosomes, vacuoles, and plasma membrane as well as for
proteins secreted extracellularly. It contains a multitude of
folding enzymes and chaperones to perform this function
(Ellgaard et al., 1999; Zapun et al., 1999). Failure in folding or
in the assembly of multimeric complexes leads to recogni-
tion by the quality control machinery in the ER. The proteins
are then transported back into the cytoplasm, most likely via
the Sec61 translocon, and degraded by the ubiquitin–protea-
some system (Kopito, 1997; Sommer and Wolf, 1997; Brod-
sky and McCracken, 1999; Plemper and Wolf, 1999). Polyu-
biquitination is mediated through the action of the E2
enzymes, Ubc1p and Ubc7p, and the membrane bound
RING-H2 ubiquitin–protein ligase (E3) Der3/Hrd1p, which
is complexed to another membrane protein, Hrd3p (Hiller et
al., 1996; Plemper et al., 1999; Friedla¨nder et al., 2000; Gard-
ner et al., 2000; Bays et al., 2001a; Deak and Wolf, 2001). The
final degradation is carried out by the proteasome, a multi-
catalytic and multifunctional proteinase machinery (Hilt
and Wolf, 2000). Depending on the nature of the malfolded
substrate protein, additional components of the ubiquitina-
tion machinery (i.e., the ubiquitin conjugating enzyme [E2
Ubc6p; Biederer et al., 1996; Hiller et al., 1996) and of the
lumenal ER folding machinery (the Hsp70 chaperone Kar2p,
protein-disulfide isomerase [PDI], -1,2 mannosidase, the
lectin-like protein Mnl1/Htm1 (Knop et al., 1996b; Plemper
et al., 1997; Brodsky et al., 1999; Gillece et al., 1999; Jakob et al.,
2001; Nakatsukasa et al., 2001) or an ER membrane protein of
unknown function (Der1p; Knop et al., 1996a) are required
for the degradation event.
We had previously shown that a defect in ERD1, involved
in the retrieval of HDEL-containing proteins from the Golgi
to the ER (Hardwick et al., 1990), leads to the escape of CPY*
from the ER, despite the fact that CPY* does not contain the
HDEL retrieval sequence (Knop et al., 1996a). We were,
therefore, interested in the question whether the secretory
competence of the ER in general is necessary for the degra-
dation of malfolded proteins. Intracellular transport of pro-
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teins is mediated by coated vesicles: proteins are packed into
COPII-coated vesicles at ER exit sites and transported to the
Golgi apparatus, where they fuse with the target membrane
(Rothman and Wieland, 1996; Schekman and Orci, 1996;
Kuehn et al., 1998). On arrival at the Golgi complex proteins
are sorted to the peripheral compartments of the cell such as
vacuoles, plasma membrane, and secretory vesicles. Proteins
can also be retrieved to the ER by retrograde transport from
either the ER-Golgi intermediate compartment or the Golgi
complex itself, by COPI-coated vesicles (Letourneur et al.,
1994; Allan and Balch, 1999).
It has been previously shown that extensive protein mis-
folding and accumulation in the ER activates the unfolded
protein response (UPR; Knop et al., 1996a; Chapman et al.,
1998; Casagrande et al., 2000; Friedla¨nder et al., 2000; Travers
et al., 2000). Signaling of malfolded proteins in the ER occurs
via Ire1p, a kinase/nuclease of the ER and the nuclear en-
velope, which activates the transcription factor Hac1p. This
activation leads to transcriptional upregulation of genes nec-
essary to relieve the cell from ER stress (Chapman et al.,
1998). As one might expect, genes involved in ER degrada-
tion directly, such as DER1, DER3/HRD1, HRD3, and UBC7
are targets of Hac1p (Travers et al., 2000). Furthermore,
transcription of genes involved in ER-to-Golgi trafficking,
protein targeting to the vacuole and the cell surface, lipid
metabolism, and glycosylation are also upregulated upon
ER stress (Travers et al., 2000). In this study, we investigated
the requirement of a fully operational early secretory path-
way and a competent UPR for efficient ER degradation. As a
soluble model substrate of ER degradation in yeast we ex-
amined the disappearance of malfolded carboxypeptidase
yscY (CPY*; Finger et al., 1993; Hiller et al., 1996; Knop et al.,
1996a). In addition, we tested the influence of defective ER
degradation on the secretory system.
MATERIALS AND METHODS
Construction and Growth Conditions of Strains
Previously described standard methods were used in media prep-
aration and for genetic and molecular biological techniques (Guthrie
and Fink, 1991; Ausubel, 1992). The Saccharomyces cerevisiae strains
used in this study are summarized in Table 1. Yeast cells were
grown at 25°C (temperature-sensitive strains) or 30°C. For genera-
tion of the ufe1-1 integration plasmid, pUT1 (Lewis et al., 1997),
containing the ufe1-1 allele, was digested with SalI and SpeI, and the
1450 base-pair ufe1-1 fragment was ligated into pRS306 (Sikorski
and Hieter, 1989) to obtain pCT27. SnaBI linearized pCT27 was used
to replace the chromosomal UFE1 allele by two-step gene replace-
ment (Scherer and Davis, 1979). RSY281 (sec23-1; Kaiser and Schek-
man, 1990), CBY263 (sed5-1; Cao et al., 1998), and RSY277 (sec21-1;
Letourneur et al., 1994) were backcrossed multiple times through
W303-1C or YCT458 to obtain the isogenic strains YCT441, YCT480,
and YCT611, respectively. The IRE1 gene was deleted using plasmid
pJU341, containing the IRE1 knock out fragment (Friedla¨nder et al.,
2000). Crossing of the respective single mutants to each other pro-
duced the double-mutant strains YCT541 and YCT542. To obtain
strains YCT458, YCT462, YCT460, YCT437, and YCT438, BglII lin-
earized plasmid pRS306prc1-1 (Knop et al., 1996a) was used to
introduce the prc1-1 allele into strains YR1070 (wild-type), YR1068
(sec12-1), YR1069 (sec18-1; H. Rudolph), RH448 (wild-type), and
RH2688 (sec27-1; Schro¨der-Ko¨hne et al., 1998) using two-step gene
replacement (Scherer and Davis, 1979). YCT614 was generated from
strain YCT438 by deleting the PEP4 gene with PvuII-digested
pWO139. Integration was confirmed by Southern blotting. Plasmid
pWO139 was generated through ligation of the 1.1-kb URA3 con-
taining an EcoRI/SmaI fragment from Yep24 (Botstein et al., 1979)
into EcoRI/MscI digested plasmid pWO261. For generation of plas-
mid pWO261 a 1.9-kb SacI/XhoI fragment from pTZ18 (Rupp and
Wolf, 1995), containing PEP4, was ligated into pBluescript KS
(Stratagene, La Jolla, CA).
To express CPY*-HA, we fused prc1-1HA behind the TDH3
(pCT43) or CUP1 (pCT52) promoter. Similarly, PRC1 was fused
behind the TDH3 promoter (pCT70) for expression of CPY. The
Table 1. Yeast strains used in this study
Name Genotype Source
W303-1B Mat  ade2-1 leu2-3,112 trp1-1 ura3-1 his3-11,15 can1-100 Chiang and Schekman (1991)
W303-1C W303-1B prc1-1 Knop et al. (1996a)
W303-CD W303-1C der1URA3 Knop et al. (1996a)
W303-CF W303-1C pep4HIS3 Knop et al. (1996a)
W303-CDF W303-1C der1URA3 pep4HIS3 Knop et al. (1996a)
W303-BD W303-1B der1URA3 Knop et al. (1996a)
YJB009 W303-1C der3/hrd1HIS3 Bordallo et al. (1998)
W303 C W303-1B prc1LEU2 Plemper et al. (1999)
YCT431 W303-1C ufe1-1 This work
YCT441 W303-1C sec23-1 This work
YCT480 W303-1C sed5-1 This work
YRH68 W303-1C ire1LEU2 This work
YCT542 W303-1C sec23-1 ire1LEU2 This work
YCT540 W303-1C ufe1-1 ire1LEU2 This work
YCT458 Mat a ura3-52 prc1-1 This work
YCT462 YCT458 sec12-1 This work
YCT460 YCT458 sec18-1 This work
YCT611 YCT458 sec21-1 This work
YCT437 Mat a prc1-1 his4 lys2 ura3 leu2 bar1 This work
YCT438 YCT437 sec27-1 This work
YCT614 YCT437 sec27-1 pep4URA3 This work
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cloning strategy to obtain plasmids pCT41, pCT43, pCT52, and
pCT70 is available on request. The yeast strain bearing the prc1-1HA
allele was obtained according to M. Longtine (Longtine et al., 1998)
using plasmid pFA6a-3HA-kanMX6. For generation of plasmid
pWO152, a 3-kb BamHI/HindIII fragment, containing SEC18, was
ligated into pRS426 (Christianson et al., 1992).
Pulse-chase Analysis
Yeast strains were grown logarithmically in CM medium and la-
beled for 20 min with 35S-methionine (pulse). Temperature-sensitive
strains were shifted to 37°C for the times indicated in legends to
figures. After addition of an excess of nonradioactive methionine,
samples were taken at the indicated time points. Cell disruption,
immunoprecipitation, and SDS-PAGE were performed as previ-
ously described (Plemper et al., 1999). Curves were generated plot-
ting the mean values of two to four independent experiments.
Maturation analysis of CPY and proteinase yscA (PrA) was per-
formed similarly, except that the strains were labeled for only 5 min.
Electron Microscopy
For immuno-electron microscopy (EM), cells were fixed in a mixture
of freshly prepared 4% formaldehyde and 0.5% glutaraldehyde in
0.1 M citrate buffer. Temperature and pH were chosen according to
growth conditions, as described previously (Ka¨rgel et al., 1996;
Zimmer et al., 1997). Cells were washed with PBS, and then 1%
sodium metaperiodate was added for 1 h to prepare the cell wall for
the penetration of the cryoprotectant. The hydrated specimens were
immersed in a cryoprotectant mixture of 25% polyvinyl-pyrrolidone
(PVP, K15/MW 10000; Fluka, Buchs, Switzerland) and 1.6 M su-
crose, as described in Tokuyasu (1989). To reach complete immer-
sion of the cryoprotectant, incubation at 30°C for 2–3 h was strictly
necessary. The cells were subsequently mounted on specimen hold-
ers, frozen in liquid nitrogen, and sectioned at 115°C with an
ultracryotom Ultracut S attached with a FCS unit (Leica, Heerbrugg,
Switzerland). Ultra-thin, thawed cryosections were prepared with
glass knifes and placed on formvar/carbon-coated copper grids
(200 mesh, hexagonal).
Labeling with primary antibodies and immunogold-complexes
(12 nm) was performed according to Griffiths (1993). Finally, the
frozen-thawed sections were stained and stabilized using a mixture
of freshly prepared 3% tungstosilicic acid hydrate (STA; Fluka) and
2.5% polyvinylalcohol (Mr 10,000; Sigma, Deisenhofen, Germany).
CPY* Secretion
Cells were grown to late log phase and then sedimented by centrif-
ugation at 500  g for 5 min. Cells were washed once with ice-cold
water and centrifuged again, and the supernatants from both cen-
trifugation steps were combined. Proteins were precipitated with
trichloroacetic acid (10%) for 30 min on ice and sedimented for 15
min at 12,000  g. The pellet was washed twice with ice-cold
acetone and dissolved in 100 l urea buffer (5% SDS, 8 M urea, 200
mM Tris-HCl, pH 6.8, 0.1 mM EDTA 1.5% dithiothreithol, 0.03%
bromophenol blue). To obtain the intracellular fraction of CPY*, an
amount of cells corresponding to 2 OD600 were alkaline lysed (Hiller
et al., 1996), and the samples were subjected to SDS-PAGE and
immunodetection as described previously (Knop et al., 1996a).
Cycloheximide Chase
Cells were grown to log phase at 25°C and incubated for 1 h at 37°C.
Cycloheximide was added (0.25 mg/ml), and 2 OD of cells were
taken after 0 and 60 min of chase. Cell extracts were prepared by
alkaline lysis method (Hiller et al., 1996), and the samples were
subjected to SDS-PAGE followed by immunodetection (Knop et al.,
1996a).
Antisera
Polyclonal anti-CPY and polyclonal anti-PrA sera were described
previously (Finger et al., 1993); anti-Emp47p serum was a generous
gift of H. Riezman (Schro¨der et al., 1995). Monoclonal anti-CPY and
anti-PGK sera were purchased from Molecular Probes (Eugene,
OR), HRPO-conjugated anti-mouse antibody from Sigma, monoclo-
nal anti-HA antibody from Babco (HA.11; Berkley, CA), and anti-
mouse immunogold-complexes (12 nm) from Dianova (Hamburg,
Germany).
RESULTS
We analyzed the degradation of CPY* in mutants defective
in anterograde transport between the ER and Golgi. We
used the mutant alleles sec12-1, sec23-1, ufe1-1, sed5-1, and
sec18-1, which block vesicular transport at restrictive condi-
tions (Stevens et al., 1982; Hardwick and Pelham, 1992;
Lewis and Pelham, 1996). Sec12p, the nucleotide-exchange
factor, which recruits Sar1p to the ER membrane (Campbell
and Schekman, 1997), and Sec23p (Kuehn et al., 1998;
Springer and Schekman, 1998) are both necessary for COPII-
coated vesicle formation. Ufe1p (Lewis et al., 1997; Patel et
al., 1998) and Sed5p (Banfield et al., 1995; Wooding and
Pelham, 1998; Tsui and Banfield, 2000) are t-SNAREs of the
ER and Golgi, respectively. They are involved in the fusion
of vesicles with the target membrane. Sec18p, the yeast
homologue of the mammalian NSF, is required for vesicular
transport in multiple stages of the secretory pathway (Gra-
ham and Emr, 1991; Mayer et al., 1996). A defect in any of
these proteins leads to a considerably reduced degradation
rate of CPY* (Figure 1, A and B). The half-life of CPY*
increases 2- (sec12-1, sec23-1, and sed5-1) to 6- (ufe1-1) fold
in mutant cells compared with wild type. We had previously
analyzed the function of Sec18p in the degradation of CPY*
and PrA*, a rapidly degraded mutant form of proteinase
yscA (Finger et al., 1993). Because the data had not been
quantified, we had concluded that both misfolded proteins
were degraded under restrictive conditions in sec18-1 cells.
Reinvestigation and quantification of CPY* degradation in
these sec18-1 mutant cells, however, revealed a 6- to 7-fold
increase in the half-life of CPY* (Figure 1B). The block of
anterograde transport between ER and Golgi was confirmed
by monitoring the maturation of proteinase yscA (PrA) in
the mutant strains at restrictive conditions. In case of the
ufe1-1 strain, a tiny fraction of matured PrA was visible after
60 min of chase; all the other mutants retained PrA in the
proform (Figure 1, C and D). The degradation of CPY*
observed in the sec12-1 mutant cells might be due to the
action of a close homologue, Sed4p, which is also involved
in the generation of COPII-coated vesicles at the ER mem-
brane (Gimeno et al., 1995). We tested if a deletion of SED4
influences the degradation rate of CPY*, either as a single
knockout or in conjunction with the sec12-1 mutation. In
both cases there was no detectable change in the half-life of
CPY* (our unpublished results).
Ufe1p is known to function in two different membrane
fusion events: it is involved in the homotypic fusion of ER
membranes and in the heterotypic fusion of COPI-coated
vesicles with the ER membrane. To distinguish between the
two different fusion events, we overexpressed the AAA-
ATPases Cdc48p and Sec18p in temperature-sensitive ufe1-1
mutant cells. CDC48p is involved in homotypic membrane
fusion, whereas Sec18p is the homologue used in heterotypic
C. Taxis et al.
Molecular Biology of the Cell1808
fusion of COPI vesicles with the ER membrane (Lewis et al.,
1997; Patel et al., 1998). Overexpression of Cdc48p rescued
the temperature sensitivity of the ufe1-1 mutant (Patel et al.,
1998) but was unable to enhance the degradation of CPY*
(our unpublished results). Overexpression of Sec18p, on the
other hand, did not rescue the temperature sensitivity of the
ufe1-1 mutant (our unpublished results) but, interestingly,
was able to partially overcome the ufe1-1–mediated degra-
dation defect of CPY* in cells under restrictive conditions
(Figure 2A).
As a control, we tested if Sec1p, a protein involved in
docking of secretory transport vesicles to the plasma mem-
brane (Novick and Schekman, 1979; Aalto et al., 1997), is
involved in ER degradation. As expected, a temperature-
sensitive mutant, sec1-1, did not alter the degradation of
CPY* under restrictive conditions compared with wild type
(our unpublished results). This rules out any unspecific in-
fluence of defects connected to various sec mutant alleles on
ER degradation (Mizuta and Warner, 1994).
Using the DNA microarray technique, Travers and co-
workers could show that transcription of many genes in-
volved in ER-Golgi transport is upregulated upon stress in
the ER. Transcription of Sec23p is enhanced by induction of
the UPR, whereas transcription of Ufe1p is not (Travers et al.,
2000). Previous studies did not find an alteration in CPY*
degradation in ire1 cells under nonstress conditions at 30°C
(Friedla¨nder et al., 2000). However, we observed that the
degradation rate of CPY* is prolonged in ire1 cells at 37°C.
To examine whether there is a synergistic effect between
UPR and ER-Golgi transport, we combined the ire1 muta-
tion with mutations in Sec23p and Ufe1p. Indeed, double
mutants of ire1 with either ufe1-1 or sec23-1 resulted in
nearly complete arrest of CPY* degradation under restrictive
conditions (Figure 2, B and C).
Consequently, we tested if a block in retrograde transport
from the Golgi to the ER would influence the degradation
rate of CPY* as much as a block in anterograde transport
does. We measured the degradation of CPY* in yeast cells
defective in Sec21p or Sec27p, two components of the COPI
complex (Hosobuchi et al., 1992; Duden et al., 1994; Letour-
neur et al., 1994). As shown in Figure 3, A and B, degradation
of CPY* is only moderately affected in sec21-1 or sec27-1 cells
at restrictive conditions. It is known that proteins, which
cannot be retrograde transported from the Golgi to the ER,
may travel to the vacuole for degradation. Therefore, we
combined a mutation in Sec27p with a deletion of the PEP4
gene, leading to a proteolysis defective vacuole (Knop et al.,
1993; Van Den Hazel et al., 1996), to check if vacuolar deg-
radation contributes to the decay of CPY* in this COPI
mutant. We found that degradation of CPY* was not altered
in the double mutant (Figure 3B), whereas a pep4 single
mutant degrades CPY* like a wild-type strain (our unpub-
lished results and Figure 5B). Anterograde transport is par-
tially affected in sec21-1 and to a lesser degree in sec27-1 cells
(Letourneur et al., 1994). We measured the maturation pro-
cess of PrA, applying the conditions for the CPY* degrada-
tion experiment, and found that in fact PrA is not fully
matured in the mutant cells after 60 min of chase (Figure
3C). In wild-type cells 80% of PrA is matured after 60 min of
chase, whereas in sec21-1 cells only 64% and in sec27-1 cells
74% is in the mature form. Retrograde transport is defective
in these two mutants at 37°C. It is known that Emp47p is
Figure 1. CPY* degradation is impaired in mutants defective in
ER-to-Golgi transport. Pulse-chase analysis was performed to measure
CPY* degradation and maturation of PrA in wild-type and isogenic
mutant strains. Cells were shifted to restrictive temperature 5 min
before the chase and lysed at the indicated time points. CPY* or PrA
were immunoprecipitated and separated by SDS-PAGE. Quantifica-
tion was done using a PhosphorImager. (A) Formation of COPII-
coated vesicles (Sec23p) and ER and Golgi t-SNARES (Ufe1p and Sed
5p) are necessary for efficient degradation of CPY*. (B) CPY* degrada-
tion requires a functional Sar1p activating factor (Sec12p) and yeast
NSF (Sec18p). (C and D) Transport is blocked in the mutant strains as
evidenced by the maturation defect of PrA (pPrA, p1 PrA precursor of
the ER; mPrA, mature PrA of the vacuole).
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degraded in the vacuole, when its recycling via COPI-coated
vesicles is inhibited (Lewis and Pelham, 1996; Schro¨der-
Ko¨hne et al., 1998). We, therefore, tested the stability of
Figure 3. CPY* degradation is affected only moderately in cells de-
fective in COPI-coated vesicle formation at restrictive temperature.
Pulse-chase analysis was performed as described in Figure 1, except
that the cells were shifted to restrictive temperature 60 min before the
chase. (A) CPY* degradation in isogenic wild-type and sec21-1 mutant
strain. (B) CPY* degradation in isogenic wild-type, sec27-1, and sec27-1
pep4 mutant strains. (C) Maturation of PrA was measured in a pulse-
chase experiment in COPI mutant and isogenic wild-type strains. The
experiment was done as described for Figure 3A, except that the cells
were labeled with radioactive methionine for 10 min. (D) COPI-coated
vesicle transport is affected in the mutant strains under the conditions
used. Emp47p degradation was followed in a cycloheximide chase
experiment after a 60-min preincubation at 37°C. Equal amounts of
cells were taken at the indicated time points. Pgk1p served as a loading
control.
Figure 2. (A) Over expression of Sec18p partially suppresses the
CPY* degradation defect of ufe1-1 mutant cells. Vector (pRS426) or
SEC18 on a high copy plasmid (pWO152) were transformed into
wild-type (WT) and ufe1-1 mutant cells. Pulse-chase analysis was
done as described in Figure 1. (B and C) Synergistic effect of ER-
Golgi transport mutants and the unfolded protein response on
degradation of CPY*. Pulse-chase analysis was done as described in
Figure 1.
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Emp47p in sec21-1 and sec27-1 cells and found that Emp47p
is degraded rapidly in the mutants, but it is stable in the
respective wild-type cells at restrictive conditions (Figure
3D). This shows that even although retrograde transport is
defective in these cells, CPY* is degraded efficiently.
One of the possible models that would explain these re-
sults is the existence of a special ER-derived compartment
for degradation, as proposed recently for mammalian cells
by Kamhi-Nesher et al. (2001). To test this model, we ana-
lyzed the localization of CPY* by electron microscopy and
immuno-gold visualization of an HA-tagged version of
CPY*. CPY*-HA is degraded in the same way and with
similar kinetics as nontagged CPY* (our unpublished re-
sults). CPY*-HA is localized to the ER/nuclear envelope and
to the peripheral ER, whereas the later compartments of the
secretory pathway are almost free of label in wild-type cells
(Figure 4A). A yeast strain deleted in Der1p, which is defec-
tive in the degradation of CPY* (Knop et al., 1996a), was used
to analyze whether CPY*-HA is accumulating in a novel
compartment. In der1 cells, as in wild-type, most of the
CPY*-HA was found at the ER/nuclear envelope and the
peripheral ER. Additionally, CPY*-HA was found in the
Golgi apparatus and the vacuole, and a fraction was secreted
outside the cell (Figure 4, B and C). This finding comple-
ments the results of Knop et al., 1996a, who showed Golgi
glycosylation of CPY* in Der1p mutant cells. In control cells,
not expressing CPY*-HA, few gold particles can typically be
found inside the nucleus and in the cytosol but not in any
membraneous structures (Figure 4D).
The localization of CPY* was also analyzed by Western
blotting, which confirmed the EM data: in wild-type cells a
minor fraction of CPY* was secreted into the medium,
whereas in der1 and der3/hrd1 cells more CPY* appeared
in the medium (Figure 5A). Additionally, the amount of
secreted CPY* was higher than that of Kar2p in these cells, as
evidenced by a very faint Kar2p signal in the extracellular
fraction (Figure 5A). It is known that Kar2p is secreted when
the HDEL retrieval pathway is saturated (Belden and Bar-
lowe, 2001). To analyze the fate of CPY* in the vacuole, we
performed pulse-chase analysis in cells with impaired vac-
uolar degradation due to deletion of the PEP4 gene (Knop et
al., 1993; Van Den Hazel et al., 1996). In pep4 cells CPY* was
degraded as in wild-type cells; however, in der1 pep4
double mutants the degradation was slower than in der1
single mutants (Figure 5B).
The EM images revealed that in cells deficient in ER
degradation some interesting morphological changes are
visible. In these cells (der1, der3/hrd1, and hrd3) the Golgi
apparatus appears as stacked cisternae in many cells (Figure
6, B and C, and our unpublished results), whereas a typical
wild-type cell contains disconnected Golgi structures (Fig-
ure 6A). Stacked Golgi structures were previously observed
in yeast mutant cells defective in intra-Golgi transport, such
as in sec7-1 cells at nonpermissive conditions (Rambourg et
al., 1993) but rarely in wild-type cells (Rambourg et al., 1995).
Mutants defective in ER degradation (der1, der3/hrd1, and
hrd3) also exhibit a considerably proliferated ER (Figure 6D
and our unpublished results). These morphological changes
are absent in cells where ER degradation is abolished in
conjunction with the unfolded protein response. In der1
ire1 cells the ER does not proliferate and the Golgi appa-
ratus has normal appearance (our unpublished results).
These observations raised the question of whether the
morphological changes in the ER and Golgi influence the
secretory function of these organelles. To address this ques-
tion, we measured the maturation kinetics of wild-type CPY
in wild-type and der1 mutant cells. Distinct forms of CPY
reflect the transport of this enzyme from the ER via the Golgi
to the vacuole. The core glycosylated pro-CPY precursor in
the ER has a molecular mass of 67 kDa (p1CPY). In the
Golgi, the carbohydrate of CPY is modified, resulting in the
p2CPY form of 69 kDa. After transport to the vacuole, CPY
is matured (mCPY) to a final form of 61 kDa (Rendueles and
Wolf, 1988). Figure 7, A and B, shows that the transport of
wild-type CPY is not delayed to a significant degree in cells
lacking Der1p. The calculated ratio between Golgi p2CPY
and vacuolar mCPY species is almost the same in wild-type
and der1 mutant cells at the different time points (Figure
7B). However, when CPY*-HA is expressed simultaneously
with wild-type CPY in Der1p-deficient cells, the maturation
of CPY from the p2CPY Golgi form to the mature vacuolar
form is considerably delayed (Figure 7C). The ratio between
p2 and mCPY is higher in der1 than in wild-type cells when
CPY*-HA is coexpressed, indicating a slower transport of
the p2CPY form (Figure 7D). Surprisingly, the exit of pro-
CPY from the ER seems to be undisturbed: there is no
difference in the rate of disappearance of p1CPY between
wild-type and der1 cells expressing CPY*-HA (Figure 7F),
and it is also the same as that observed in wild-type cells not
coexpressing CPY or CPY*-HA (our unpublished results).
As a control, we expressed CPY exogenously in wild-type
and der1 cells and followed the maturation of CPY. Under
these conditions, every step of the process was delayed in
both strains, starting with a slower exit from the ER (Figure
7, E and F). Taken together, the EM data and the CPY
maturation experiments suggest that escape of unfolded
proteins from the ER disturbs the secretory competence of
the later stages of the secretory pathway.
DISCUSSION
Using mutants defective in ER-to-Golgi traffic, we discov-
ered a connection between the secretory competence of the
ER itself and the degradation of the ERAD substrate CPY*.
Mutants defective in Ufe1p, Sec12p, Sec23p, Sed5p, and
Sec18p exhibited an extended half-life of CPY* (Figure 1).
After completion of our studies, reports appeared that also
communicate disturbed degradation of soluble ER degrada-
tion substrates in mutants defective in ER-Golgi transport
(Caldwell et al., 2001; Vashist et al., 2001). The authors give
two explanations for the involvement of ER-to-Golgi trans-
port in ER degradation: (i) Soluble ER substrates may travel
to the Golgi and back to the ER, either to receive a modifi-
cation that enhances degradation (Caldwell et al., 2001) or as
the default route to degradation (Vashist et al., 2001). (ii)
Alternatively, an yet unidentified factor, which is required
for the degradation of soluble substrates, cycles between ER
and Golgi. In this model, the substrate itself remains in the
ER (Caldwell et al., 2001).
Our results lead to different conclusions: in the sec12-1,
sec18-1, and sec23-1 mutants, ER-to-Golgi transport is
blocked completely as evidenced by the lack of the Golgi
localized p2CPY species (Stevens et al., 1982) or by the
maturation defect of PrA (Figure 1, C and D). In contrast,
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degradation of CPY* is not completely blocked in these
mutants (Figure 1, A and B). Instead, degradation of CPY*
takes place at different rates in the various ER-Golgi traffick-
ing mutants tested; the delay in degradation ranges between
a factor of 2 (sec12-1, sec23-1, and sed5-1 mutant strains) and
6–7 (sec18-1 and ufe1-1 mutants). Deletion of Sed4p, a close
Figure 4. Localization of CPY*-HA by immuno-EM. Ultra-thin cryosections of wild-type (A) and Der1p-deleted cells (B and C) expressing
HA-tagged CPY* or wild-type cells without tag (D) were labeled with antibodies against HA and anti-mouse-gold complexes (12 nm). Yeast
strains in A, B, and C were transformed with plasmid pCT52, carrying CPY*-HA under the control of the CUP1 promoter. The expression
of CPY*-HA was induced with addition of copper sulfate (100 M final concentration) for 3 h. (A) CPY*-HA is localized to the ER in wild-type
cells. (B) CPY*-HA is distributed in structures of the secretory system in der1 cells. (C) der1 cells secrete CPY*-HA to the outside of the cell.
(D) Unspecific staining of the used antibodies in wild-type cells. N, nucleus; M, mitochondrion; V, vacuole; G, Golgi elements. Bars, 500 nm.
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homologue of Sec12p, in the presence of the sec12-1 muta-
tion, did not enhance the half-life of CPY*. Because ER-to-
Golgi traffic is blocked in these mutants, it is hard to envis-
age how some CPY* could still reach the Golgi to receive a
specific modification or why the degradation route would be
changed in sec12-1, sec23-1, or sed5-1 but not in sec18-1 or
ufe1-1 cells. In COPI mutant cells (sec21-1 and sec27-1), only
a moderate alteration in the degradation of CPY* compared
with wild-type is visible (Figure 3, A and B), despite the fact
that retrograde traffic from the Golgi to the ER is defective
(Figure 3D and Letourneur et al., 1994). If CPY* would travel
to the Golgi and back to the ER before degradation, one
would expect a much larger influence of COPI-coat mutants
on degradation of CPY*. Because the half-life of CPY* is not
increased in sec27-1 pep4 double-mutant cells, we conclude
that the vacuole does not contribute to the degradation seen
in sec27-1 cells (Figure 3B). All together, the transport defects
of the various mutants cannot be correlated with the degra-
dation pattern of CPY*. These findings, therefore, argue
against the idea of a relocation of CPY* to the Golgi and then
back to the ER or of the recycling of a proteinaceous factor
between these compartments for efficient degradation of
CPY*. Only a yet-unknown Golgi-ER retrieval mechanism
could possibly apply for a cycling-dependent degradation
mechanism. Another recent publication reports that muta-
tions in the early secretory pathway severely affect the struc-
ture of the ER (Prinz et al., 2000). They show that ufe1-1 or
sec23-1 mutant cells, two mutants also used in our studies,
exhibit a dramatically reduced amount of peripheral ER and
a considerably disorganized organelle at nonpermissive
temperature (Prinz et al., 2000). We find that under the same
conditions degradation of CPY* is prolonged in these mu-
tants (Figure 1A). Another possible explanation is that the
mislocalization of Kar2p observed in various ER-Golgi
transport mutants (Nishikawa et al., 1994) leads to defective
degradation. Kar2p is necessary for degradation of CPY*
(Plemper et al., 1997) but is not involved in the degradation
of membrane proteins (Plemper et al., 1998; Kiser et al., 2001;
Zhang et al., 2001). This model would explain why mis-
folded membrane proteins are degraded efficiently in the
ER-Golgi transport mutants (Biederer et al., 1996; Katzmann
et al., 1999; Vashist et al., 2001), whereas CPY* is not. Taken
together, we conclude that the morphological disturbance of
the ER, mislocalization of Kar2p, or both, are the cause of the
changes in CPY* degradation. Analysis of the localization of
HA-tagged CPY* via immuno-gold EM revealed that the
protein resides at the ER/nuclear envelope and the periph-
eral ER. These EM images do not indicate the existence of a
novel compartment, specialized in ER degradation (Figure 4,
A–C), as recently proposed for mammalian cells (Kamhi-
Nesher et al., 2001). In the light of the EM data, the degra-
dation behavior of CPY* in the ER-Golgi transport mutants
as well as the data of Prinz et al. (2000) and Nishikawa et al.
(1994), we suggest that the decrease in degradation of CPY*
is due to indirect or secondary effects caused by the muta-
tions that lead to impaired ER-Golgi transport. The severe
alteration in CPY* degradation observed in double mutants
defective in Sec23p or Ufe1p and UPR signaling due to
deletion of Ire1p (Figure 2, B and C), can be explained
similarly: the amount of ER is diminished, chaperones like
Kar2p are mislocalized, and the possibility to increase ex-
pression of proteins involved in ER-stress relieve is abol-
ished. Recovery of CPY* degradation upon overexpression
of Sec18p in ufe1-1 mutants indicates that the involvement of
Ufe1p in vesicular transport is necessary to maintain proper
CPY* degradation and that this is independent of its in-
volvement in homotypic membrane fusion exerted together
with Cdc48p (Figure 2A). Recent studies show that Cdc48p
does indeed take part in CPY* degradation, being involved
in retro-translocation of the malfolded protein into the cy-
tosol (Ye et al., 2001; Bays et al., 2001b; Rabinovitch et al.,
2002; Jarosch et al., 2002).
The ER is considerably enlarged in der1, der3/hrd1, and
hrd3 cells (Figure 6D and our unpublished results). This
alteration is most likely controlled by the UPR, because
many genes involved in lipid metabolism are also upregu-
lated upon ER stress (Travers et al., 2000). As expected, a
der1 ire1 double knockout strain has no proliferated ER
(our unpublished results). The appearance of Golgi stacks
could indicate a defect in intra-Golgi transport in the mu-
tants deficient in ER degradation, which is less severe than
the one seen in the sec7-1 mutant at restrictive conditions but
significant enough to change the morphology of the or-
ganelle. On disruption of CPY* degradation by deletion of
Der1p, we find some CPY*-HA in the Golgi apparatus, in the
vacuole and in secreted form (Figure 4, B and C). This
indicates a “leakage” of CPY*-HA out of the ER under these
conditions. In addition, in a strain deleted for Der1p and
Pep4p, CPY* has a longer half-life than in a strain lacking
only Der1p, indicating transport of a fraction of CPY* into
the vacuole. This finding complements the observation of
Knop et al. (1996a), who reported some Golgi glycosylation
Figure 5. (A) CPY* is secreted into the medium. Cellular and
secreted CPY* was analyzed by SDS-PAGE and immunodetection.
The same blot was reprobed against Kar2p. Approximately five
times more material was loaded in the extracellular fraction. (B)
Vacuolar hydrolysis contributes to degradation of CPY* in der1
cells. Degradation of CPY* was measured by pulse-chase analysis in
yeast strains defective in vacuolar hydrolysis (pep4), ER degrada-
tion (der1), or double mutants (pep4 der1).
ER Degradation Requires ER-Golgi Traffic
Vol. 13, June 2002 1813
of CPY* in der1 cells. Soluble, misfolded proteins can es-
cape from the ER when their degradation is abolished. The
reason is probably the saturation of the retrieval pathway
from the Golgi back to the ER when too many unfolded
proteins are present in the ER. It is known that the HDEL
receptor takes part in the retention of unfolded proteins in
the ER by recycling them back from the Golgi (Knop et al.,
1996a; Yamamoto et al., 2001). Unfolded proteins that escape
the retention machinery travel along the secretory pathway
to the vacuole or are secreted (Figures 4, B and C, and 5).
Figure 6. Morphology of secretory organelles is changed in mutants defective in ER degradation. (A) Wild-type. (B) Golgi structure in der1
cells. (C) Golgi structures present in Der3/Hrd1p-deficient cells. (D) ER proliferates in der3/hrd1 cells. N, nucleus; M, mitochondrion; V,
vacuole; ER, endoplasmic reticulum. Bars, 1000 and 500 nm, respectively.
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This seems to disturb the secretory pathway in a yet un-
known way, as delivery of wild-type CPY from the Golgi to
the vacuole is delayed in der1 cells simultaneously express-
ing malfolded CPY*-HA (Figure 7). This delay can be ex-
plained by a defect in transport through the Golgi due to the
presence of misfolded proteins or, alternatively, by a com-
petition between CPY and CPY*-HA for the CPY sorting
receptor, Vps10p (Stack et al., 1995). Perturbations in vacu-
olar function may also explain this phenomenon. The mat-
uration defect observed in der1 cells coexpressing
CPY*-HA is not simply a consequence of overloading in the
secretory pathway. Overloading through expression of ad-
ditional CPY results in slower transport in every step of the
secretory pathway, e.g., the half-life in exit from the ER is
roughly doubled (Figure 7F). In der1 cells expressing
CPY*-HA only the later transport or maturation steps are
affected, which seems to be a consequence of unfolded pro-
teins present in the secretory pathway (Figure 7, C and D).
The data presented here indicate that efficient ER degrada-
tion requires an ER fully competent in secretion and, vice
versa, that efficient secretion depends on an undisturbed
quality control machinery in the ER.
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